0

500

1,000

1,500

2,000

2,500

3,000

3,500

JAN

FEB

MAR AP

R

MAY JUN

JUL

AUG

SEP

OCT

NO

V

DEC

Num

ber o

f new

CL c

ases

ACL 2015 ACL 2014ZCL 2015 ZCL 2014

VL ACL ZCL MCL

Endemicity status: Endemic Endemic Endemic Non endemic

Number of new cases (incidence): 8 27,787 1,605 N/A

Number of relapses1: No data 375 No data N/A

Total number of cases 8 28,162 1,605 N/AImported cases (#, %): No data No data No data No data

Gender distribution (% F): 38 50 48 N/A

Age group distribution (%, < 5/5-14/>14): (88/12/0) (23/40/37) (42/27/31) N/A

Incidence rate (cases/10,000 population in endemic areas): 0.06 27.23 13.78 N/ANumber of endemic 2nd sub-national administrative level divisions: No data 254 16 N/A

Population at risk2 (%, # at risk/total population): 5% 1,606,414/32,527,000 32 % 10,340,735/

32,527,000 4 % 1,164,373/32,527,000 N/A

Was there any outbreak? No data No data No data N/A

Number of new3 foci: No data No data No data N/A

COUNTRY GENERAL INFORMATION (WHO, 2015)

Total population: 32,527,000Gender F /M (%): 49.3 / 50.7Population, age group <15/ ≥15 years (%): 47 / 53Life expectancy at birth (F/M, years) (2015): 62 / 59GDP (PPP int $): 2,000Income status: LowNumber of 2nd sub-national administrative level divisions, name: 399, District

Leishmaniasis country profile — 2015(Published Dec. 2017)

Afghanistan

EPIDEMIOLOGY

N/A = Not applicable; 1 Relapse in this country is defined as: no definition available; 2 Defined as “Number of people living in 2nd sub-national administrative level endemic areas”; 3 Defined as “In this reporting period, an area at the 2nd sub-national administrative level reporting cases for the first time ever”

Monthly distribution of new cases (January-December)

Cutaneous leishmaniasisVisceral leishmaniasis

Incidence rate/10,000 (at the national level) and number of new cases from 1998 to 2015

2015 JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DECVL 1 2 1 1 1 1 1 0 0 0 1 0ACL 2,407 3,065 2,684 2,934 2,444 2,245 1,391 2,275 1,756 1,938 2,209 2,814ZCL 116 46 50 35 27 27 18 34 41 362 535 314VL = visceral leishmaniasis; ACL = anthroponotic cutaneous leishmaniasis; ZCL= zoonotic cutaneous leishmaniasis; MCL = mucocutaneous leishmaniasis

0

1

2

3

4

5

JAN

FEB

MAR AP

R

MAY JUN

JUL

AUG

SEP

OCT

NO

V

DEC

Num

ber o

f new

VL

case

s VL 2015 VL 2014

Num

ber o

f new

VL

case

s

Num

ber o

f new

CL

case

s

0.000

0.001

0.002

0.003

0.004

0.005

0.006

0.007

0.008

0.009

0

5

10

15

20

25

30

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Inci

denc

e ra

te (/

10 0

00)

Num

ber o

f pr

imar

y VL

cas

es

VL cases

VL incidence rate

Visceral leishmaniasis

Num

ber o

f new

VL

case

s

Inci

denc

e ra

te (/

10,0

00)

* * * * * * * * * ** * 0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

16.0

0

5000

10000

15000

20000

25000

30000

35000

40000

45000

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Incid

ence

rate

(/10

000

)

ZCL cases

ACL cases

ACL incidence rate

ZCL incidence rate

Inci

denc

e ra

te (/

10,0

00)

Cutaneous leishmaniasis

* * * * *Num

ber o

f new

CL

case

s

* No data

* No data

Disease distribution of new VL and CL cases at district level per 10,000 population (2015)Visceral leishmaniasis Cutaneous leishmaniasis

Year Leishmaniasis National Control Programme (LNCP) was established: 2007Type of surveillance: VerticalIs there a vector control programme? NoType of insecticide used for Indoor residual Spraying (IRS): Not availableYear latest national guidelines: 2014Is leishmaniasis notifiable (mandatory report)? NoIs there a reservoir host control programme? No

Number of leishmaniasis health facilities: 23

CONTROL AND SURVEILLANCE

DIAGNOSIS VL ACL ZCL MCL

Number of people screened actively for: No data No data No data N/ANumber of people screened passively for: 8 28,162 No data N/ACases diagnosed by RDT* (%, # RDT+/ total VL cases): No data N/A N/A N/AProportion of positive RDT* (%, # RDT+/total RDT): No data N/A N/A N/ACases diagnosed by direct exam* (parasitology) (%, # slides + / total cases): 100%, (8/8) No data No data N/AProportion of positive slides* (%, # slides + / total slides): 100%, (8/8) No data No data N/A

Cases diagnosed clinically* (%, # clinical cases/ total cases): 0%, (0/8) No data 100% (1,605/1,605) N/A

Proportion of CL cases with lesions equal to or greater than 4cm*: N/A No data No data N/AProportion of CL cases with 4 or more lesions*: N/A no data No data N/APercentage of cases with HIV coinfection*: 0%, (0/8) N/A N/A N/A

TREATMENT AND MEDICINESIs treatment provided for free in the public sector? YesAntileishmanial medicines included in the National Medicine List: Not available

TREATMENT OUTCOME VL ACL ZCLProportion of cases treated*(%, # treated cases/ total cases): 100% (8/8) 100 % (27,787/27,787) 100% (1,605/1,605)Initial cure rate*(%, # cases initially cured /total cases): 88% (7/8) No data No dataFailure rate4*(%, # patients with treatment failure /total cases): 0% (0/8) No data No dataCase fatality rate*(%, # patients who died/ total cases): 0% (0/8) No data No data

VL = visceral leishmaniasis; ACL = anthroponotic cutaneous leishmaniasis; ZCL= zoonotic cutaneous leishmaniasis; MCL = mucocutaneous leishmaniasis4 Failure in this country is defined as: no definition available * These indicators only apply to new cases

ACL

ZCL

The boundaries and names shown and the designations used on these maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.Map production: WHO/HTM/NTD/IDM

N/A = Not applicable; RDT = rapid diagnostic test; HIV = human immunodeficiency virus

Data source: Ministry of Health, Afghanistan© WHO, 2017. All rights reserved

www.who.int/leishmaniasis/Map-VL-Afghanistan-2015.png

www.who.int/leishmaniasis/Map-ACL-

Afghanistan-2015.png

www.who.int/leishmaniasis/Map-ZCL-

Afghanistan-2015.png